Education
About Us
Working with TipRanks
Follow Us
Immuron Ltd (IMRN)
NASDAQ:IMRN
IMRN Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.50 - $2.73
Previous CloseN/A
Volume5.19K
Average Volume (3M)58.50K
Market Cap
$15.73M
Enterprise Value$6.30M
Total Cash (Recent Filing)$2.83M
Total Debt (Recent Filing)$117.13K
Price to Earnings (P/E)―
Beta-0.24
Next Earnings
Mar 04, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.30
Shares Outstanding6,705,499
10 Day Avg. Volume91,269
30 Day Avg. Volume58,504
Financial Highlights & Ratios
PEG Ratio0.11
Price to Book (P/B)1.89
Price to Sales (P/S)2.09
P/FCF Ratio-2.49
Enterprise Value/Market Cap0.40
Enterprise Value/Revenue0.86
Enterprise Value/Gross Profit1.32
Enterprise Value/Ebitda-1.17
Forecast
1Y Price Target
$1.50Price Target Upside-33.92% Downside
Rating ConsensusHold
Number of Analyst Covering0
Immuron News
IMRN FAQ
What was Immuron Ltd’s price range in the past 12 months?
Immuron Ltd lowest stock price was $1.50 and its highest was $2.73 in the past 12 months.
What is Immuron Ltd’s market cap?
Immuron Ltd’s market cap is $15.73M.
When is Immuron Ltd’s upcoming earnings report date?
Immuron Ltd’s upcoming earnings report date is Mar 04, 2026 which is in 145 days.
How were Immuron Ltd’s earnings last quarter?
Immuron Ltd released its earnings results on Aug 28, 2025. The company reported -$0.297 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.297.
Is Immuron Ltd overvalued?
According to Wall Street analysts Immuron Ltd’s price is currently Overvalued.
Does Immuron Ltd pay dividends?
Immuron Ltd does not currently pay dividends.
What is Immuron Ltd’s EPS estimate?
Immuron Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Immuron Ltd have?
Immuron Ltd has 6,705,499 shares outstanding.
What happened to Immuron Ltd’s price movement after its last earnings report?
Immuron Ltd reported an EPS of -$0.297 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 0.549%.
Which hedge fund is a major shareholder of Immuron Ltd?
Currently, no hedge funds are holding shares in IMRN
Company Description
Immuron Ltd
Immuron Limited (ASX: IMRN) is a biopharmaceutical company focused on developing and commercializing innovative therapeutic products that target inflammatory and infectious diseases. The company specializes in developing proprietary antibodies and proteins as treatments for conditions such as liver disease and gastrointestinal disorders. Immuron's lead product, Travelan, is a dietary supplement designed to prevent travelers' diarrhea, while its other research initiatives explore treatments for autoimmune diseases and liver conditions.
Technical Analysis
Relmada Therapeutics
―
AlphaTON Capital
―
Bioxcel Therapeutics
―
Citius Pharmaceuticals
―
Hookipa Pharma
―
Ownership Overview
―
Insiders
―
Mutual Funds
0.02% Other Institutional Investors
99.98% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---